Search

Natural pollen grains were cleaned to remove all external and internal cytoplastic materials to produce sporopollenin exine capsules (SECs). SECs are empty microcapsules with extensive networks of ...

Two new levulinate-based protic ionic liquids (Lev PILs) have been synthesized through an easy, scalable neutralization reaction between levulinic acid (LA), which is one of the most promising renewable building blocks obtainable from cellulose, and amidine superbases (either DBU or DBN). The prepared PILs have been characterized (by means of NMR, FT-IR, TGA and viscosity measurements) and studied as potential cellulose dissolution media. These species display a dissolving ability (weightcellulose/weightPIL) comparable with the popular, and to date best performing, acetate-based PILs. In contrast with these systems, Lev PILs are composed of a larger renewable anion (levulinate vs. acetate): this allows for a reduced amount of the expensive non-renewable superbase cation component while only slightly affecting the cellulose dissolution performance. An application of the proposed Lev PILs, namely the levulination of cellulose, has also been studied. The impact of various reaction parameters (i.e. temperature, amount of anhydride, amount of co-solvent) on the reaction outcome and on the functionalization degree (up to 1.87) has been studied. γ-Valerolactone, a renewable green solvent which is in turn prepared from LA, has been found as an effective DMSO replacement when used as co-solvent for the reaction, allowing for satisfactory functionalization degrees.

Sporopollenin exine capsules (SECs) are empty microcapsules that are 25 μm in diameter and have extensive networks of ∼200 nm diameter holes obtained by chemically removing all external and internal cytoplastic materials from the natural pollen grains. We have demonstrated that a phase change material (PCM) such as n-eicosane (EIS), a natural paraffin wax, can be successfully encapsulated in the SECs to produce [EIS@SEC]. The high stability and robust nature of SECs retain EIS in the microcavity even during phase transitions, enabling EIS to fully maintain its phase change property while also protecting the EIS from elevated temperatures and corrosive environments. [EIS@SEC] can, therefore, be incorporated into cellulose (CEL) composites with a synthetic process that uses the simple ionic liquid butylmethylimmidazolium chloride to produce [CEL+EIS@SEC] composites. Similar to EIS alone, EIS in the [CEL+EIS@SEC] composites melts when heated and crystallizes when cooled. The energies associated with the crystallization and melting processes enable the [CEL+EIS@SEC] composites to fully exhibit the properties expected of PCMs, i.e., heating the surroundings when they cool and absorbing energy from the surroundings when they warm. The efficiency of latent heat storage and release of [CEL+EIS@SEC] composites was estimated to be around 57% relative to pure EIS. The fact that the DSC curves of the [CEL+EIS@SEC] composites remain the same after going through the heating-melting cycle 220 times clearly indicates that SEC effectively retains EIS in its cavity and protects it from leaking and that the [CEL+EIS@SEC] composites are highly stable and reliable as a phase change material. The [CEL+EIS@SEC] composites are superior to any other available materials based on encapsulated PCM because they are not only robust, reliable, and stable and have strong mechanical properties. They are also are sustainable and biocompatible because as they are synthesized from all naturally abundant materials using a green and recyclable synthesis. These features enable the [CEL+EIS@SEC] composites to be uniquely suited as high performance materials for such uses as dressings to treat burnt wounds, smart textiles for clothing, smart building materials, and energy storage.

In order to identify most suitable ionic liquids (ILs) for potential applications in infection prevention and control, in the present study we comparatively evaluated the antimicrobial potency and hemolytic activity of 15 ILs, including 11 previously described and four newly synthesized ILs, using standard microbiological procedures against Gram-positive and Gram-negative bacteria. ILs showing the lowest minimum inhibitory concentration (MIC) were tested for their hemolytic activity. Three ILs characterized by low MIC values and low hemolytic activity, namely 1-methyl-3-dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, and 1-dodecyl-1-methylpiperidinium bromide were further investigated to determine their minimum bactericidal concentration (MBC), and their ability to inhibit biofilm formation by Staphylococcus aureus or Pseudomonas aeruginosa. Killing kinetics results revealed that both Gram-positive and Gram-negative bacteria are rapidly killed after exposure to MBC of the selected ILs. Furthermore, the selected ILs efficiently inhibited biofilm formation by S. aureus or P. aeruginosa. To our knowledge, this is the first systematic study investigating the antimicrobial potential of different types of ionic liquids using standard microbiological procedures. In the overall, the selected ILs showed low hemolytic and powerful antimicrobial activity, and efficient inhibition of biofilm formation, especially against S. aureus, suggesting their possible application as anti-biofilm agents.

Selective and potent matrix metalloproteinase 12 (MMP-12) inhibitors endowed with improved hydrophilicity are highly sought for potential use in the treatment of lung and cardiovascular diseases. In the present paper, we modified the structure of a nanomolar MMP-12 inhibitor by incorporating an ionic liquid (IL) moiety to improve aqueous solubility. Four biologically active salts were obtained by linking the sulfonamide moiety of the MMP-12 inhibitor to imidazolium-, pyrrolidinium-, piperidinium-, and DABCO-based ILs. The imidazolium-based bioactive salt was tested on human recombinant MMPs and on monocyte-derived dendritic cells, showing activity similar to that of the parent compound, but improved water solubility. The imidazolium-based bioactive salt was then used to prepare electrostatically stabilized MMP inhibitor-coated gold nanoparticles (AuNPs) able to selectively bind MMP-12. These AuNPs were used to study subcellular localization of MMP-12 in monocyte-derived dendritic cells by transmission electron microscopy analysis.